This website was discontinued on 20/12/2022. Visit the new website at www.fct.pt.
The information may be unavailable due to the results not being approved or confirmed. In particular, when a call includes regions where projects are cofunded by EC funds and others where that is not the case, confirmation or approval may be not simultaneous.
Identification and characterization of Chlamydia trachomatis virulence proteins. Luís Jaime Gomes Ferreira da Silva Mota, NOVA.ID.FCT - Associação para a Inovação e Desenvolvimento da FCT (NOVA.ID.FCT). €239,075.
Find targets for Clostridium difficile infection control. Mónica Paula Fernandes Serrano Miranda, Universidade Nova de Lisboa (UNL). €238,612.
Identification of novel quorum sensing signals in the mammalian gut microbiota. Karina Xavier, Fundação Calouste Gulbenkian (FCG). €239,849.
Targeting efflux pumps in drug resistant Mycobacterium tuberculosis: an approach to prevent efflux-mediated resistance and boost therapy in active and latent tuberculosis. MIGUEL VIVEIROS BETTENCOURT, Universidade Nova de Lisboa (UNL). €239,318.
Bacterial ABC-type Multitask Energizers: one ATPase fits all? Isabel de Sá-Nogueira, NOVA.ID.FCT - Associação para a Inovação e Desenvolvimento da FCT (NOVA.ID.FCT). €238,794.
STOPneumo - Targeted approaches to contain pneumococcal disease. Raquel Sá-Leão, Universidade Nova de Lisboa (UNL). €239,261.
Role of the peptidoglycan hydrolases in the interaction of Streptococcus pneumoniae with an infected host. Sérgio Joaquim Raposo Filipe, NOVA.ID.FCT - Associação para a Inovação e Desenvolvimento da FCT (NOVA.ID.FCT). €239,792.
Clinical significance of Mycobacterium tuberculosis cell wall structural diversity: contribution to novel mechanisms of antibiotic resistance and relevance towards tuberculosis progression and treatment. Maria João Gracias Fernandes da Costa Catalão, FARM-ID, Associação da Faculdade de Farmácia para a Investigação e Desenvolvimento (FARM-ID). €238,647.
Fostering the development of new probiotic therapeutic approaches for the tretament of candidiasis through the exploration of lactobacilii-Candida interference mechanisms. Nuno Gonçalo Pereira Mira, Associação do Instituto Superior Técnico para a Investigação e o Desenvolvimento (IST-ID). €238,326.
Development and evaluation of a surfactant-hydrogel for preventing direct contact transmitted infections. Alexandra Isabel Cardoso Nunes, Associação para Investigação e Desenvolvimento da Faculdade de Medicina (AIDFM/FM/ULisboa). €239,956.
Staphylococcus epidermidis adaptation to nitric oxide produced by the innate immune system. Sandra Carvalho, Universidade Nova de Lisboa (UNL). €236,523.
Fighting Staphylococcus aureus - Peptidoglycan amidation as a new target. Rita Gonçalves Sobral de Almeida, NOVA.ID.FCT - Associação para a Inovação e Desenvolvimento da FCT (NOVA.ID.FCT). €239,900.
A new model system to functionally characterize gut microbiota colonization and interaction with innate immunity. Luis Manuel Valla Teixeira, Fundação Calouste Gulbenkian (FCG). €239,980.
The RNA-binding protein Hfq interactome in the human pathogen Listeria monocytogenes: piecing together the elusive role of a virulence regulator. José Marques Andrade, Universidade Nova de Lisboa (UNL). €238,073.
Molecular and cell biology of imipenem resistance in the human enteric pathogen Clostridium difficile. Adriano O Henriques, Universidade Nova de Lisboa (UNL). €239,862.